Melioidosis: epidemiology, pathophysiology, and management
- PMID:15831829
- PMCID: PMC1082802
- DOI: 10.1128/CMR.18.2.383-416.2005
Melioidosis: epidemiology, pathophysiology, and management
Erratum in
- Clin Microbiol Rev. 2007 Jul;20(3):533. Dosage error in article text
Abstract
Melioidosis, caused by the gram-negative saprophyte Burkholderia pseudomallei, is a disease of public health importance in southeast Asia and northern Australia that is associated with high case-fatality rates in animals and humans. It has the potential for epidemic spread to areas where it is not endemic, and sporadic case reports elsewhere in the world suggest that as-yet-unrecognized foci of infection may exist. Environmental determinants of this infection, apart from a close association with rainfall, are yet to be elucidated. The sequencing of the genome of a strain of B. pseudomallei has recently been completed and will help in the further identification of virulence factors. The presence of specific risk factors for infection, such as diabetes, suggests that functional neutrophil defects are important in the pathogenesis of melioidosis; other studies have defined virulence factors (including a type III secretion system) that allow evasion of killing mechanisms by phagocytes. There is a possible role for cell-mediated immunity, but repeated environmental exposure does not elicit protective humoral or cellular immunity. A vaccine is under development, but economic constraints may make vaccination an unrealistic option for many regions of endemicity. Disease manifestations are protean, and no inexpensive, practical, and accurate rapid diagnostic tests are commercially available; diagnosis relies on culture of the organism. Despite the introduction of ceftazidime- and carbapenem-based intravenous treatments, melioidosis is still associated with a significant mortality attributable to severe sepsis and its complications. A long course of oral eradication therapy is required to prevent relapse. Studies exploring the role of preventative measures, earlier clinical identification, and better management of severe sepsis are required to reduce the burden of this disease.
Figures



Similar articles
- Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei.Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ.Wiersinga WJ, et al.Nat Rev Microbiol. 2006 Apr;4(4):272-82. doi: 10.1038/nrmicro1385.Nat Rev Microbiol. 2006.PMID:16541135Review.
- Melioidosis.Wiersinga WJ, Virk HS, Torres AG, Currie BJ, Peacock SJ, Dance DAB, Limmathurotsakul D.Wiersinga WJ, et al.Nat Rev Dis Primers. 2018 Feb 1;4:17107. doi: 10.1038/nrdp.2017.107.Nat Rev Dis Primers. 2018.PMID:29388572Free PMC article.Review.
- Melioidosis: a clinical overview.Limmathurotsakul D, Peacock SJ.Limmathurotsakul D, et al.Br Med Bull. 2011;99:125-39. doi: 10.1093/bmb/ldr007. Epub 2011 May 9.Br Med Bull. 2011.PMID:21558159Review.
- Melioidosis: advances in diagnosis and treatment.Cheng AC.Cheng AC.Curr Opin Infect Dis. 2010 Dec;23(6):554-9. doi: 10.1097/QCO.0b013e32833fb88c.Curr Opin Infect Dis. 2010.PMID:20847695Review.
- A case report of Tubo-ovarian abscess caused by Burkholderia pseudomallei.Nernsai P, Sophonsritsuk A, Lertvikool S, Jinawath A, Chitasombat MN.Nernsai P, et al.BMC Infect Dis. 2018 Feb 8;18(1):73. doi: 10.1186/s12879-018-2986-z.BMC Infect Dis. 2018.PMID:29422033Free PMC article.
Cited by
- Identification and mechanism determination of the efflux pump subunit amrB gene mutations linked to gentamicin susceptibility in clinical Burkholderia pseudomallei from Malaysian Borneo.Hussin A, Nathan S, Shahidan MA, Nor Rahim MY, Zainun MY, Khairuddin NAN, Ibrahim N.Hussin A, et al.Mol Genet Genomics. 2024 Feb 21;299(1):12. doi: 10.1007/s00438-024-02105-w.Mol Genet Genomics. 2024.PMID:38381232
- Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious.Ceballos-Olvera I, Sahoo M, Miller MA, Del Barrio L, Re F.Ceballos-Olvera I, et al.PLoS Pathog. 2011 Dec;7(12):e1002452. doi: 10.1371/journal.ppat.1002452. Epub 2011 Dec 29.PLoS Pathog. 2011.PMID:22241982Free PMC article.
- Surprisingly low seroprevalence of Burkholderia pseudomallei in exposed healthy adults in the Darwin region of tropical Australia where melioidosis is highly endemic.James GL, Delaney B, Ward L, Freeman K, Mayo M, Currie BJ.James GL, et al.Clin Vaccine Immunol. 2013 May;20(5):759-60. doi: 10.1128/CVI.00021-13. Epub 2013 Mar 27.Clin Vaccine Immunol. 2013.PMID:23536689Free PMC article.
- Whole-Genome Sequence of an Epidemic Strain of Burkholderia pseudomallei vgh07 in Taiwan.Chen YS, Lin HH, Hsueh PT, Liu PJ, Ni WF, Chung WC, Lin CP, Chen YL.Chen YS, et al.Genome Announc. 2015 Apr 30;3(2):e00345-15. doi: 10.1128/genomeA.00345-15.Genome Announc. 2015.PMID:25931599Free PMC article.
- RegAB Homolog of Burkholderia pseudomallei is the Master Regulator of Redox Control and involved in Virulence.Phenn J, Pané-Farré J, Meukow N, Klein A, Troitzsch A, Tan P, Fuchs S, Wagner GE, Lichtenegger S, Steinmetz I, Kohler C.Phenn J, et al.PLoS Pathog. 2021 May 28;17(5):e1009604. doi: 10.1371/journal.ppat.1009604. eCollection 2021 May.PLoS Pathog. 2021.PMID:34048488Free PMC article.
References
- Abbink, F. C., J. M. Orendi, and A. J. de Beaufort. 2001. Mother-to-child transmission of Burkholderia pseudomallei. N. Engl. J. Med. 344:1171-1172. - PubMed
- Acute Respiratory Distress Syndrome Network. 2000. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 342:1301-1308. - PubMed
- Ahmed, K., H. D. Enciso, H. Masaki, M. Tao, A. Omori, P. Tharavichikul, and T. Nagatake. 1999. Attachment of Burkholderia pseudomallei to pharyngeal epithelial cells: a highly pathogenic bacteria with low attachment ability. Am. J. Trop. Med. Hyg. 60:90-93. - PubMed
- Alejandria, M. M., M. A. Lansang, L. F. Dans, and J. B. Mantaring. 2001. Intravenous immunoglobulin for treating sepsis and septic shock (Cochrane Review). Cochrane Database Syst. Rev. 2:CD001090. - PubMed
- Alibek, K. 1998. Statement by Dr. Kenneth Alibek. Terrorist and intelligence operations: potential impact on the U.S. economy. Joint Economic Committee, U.S. Congress, Washington, D.C.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical